Sather Financial Group Inc Has $6.42 Million Holdings in UnitedHealth Group Incorporated $UNH

Sather Financial Group Inc increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1,252.5% in the second quarter, Holdings Channel reports. The firm owned 20,585 shares of the healthcare conglomerate’s stock after buying an additional 19,063 shares during the quarter. UnitedHealth Group accounts for approximately 0.4% of Sather Financial Group Inc’s holdings, making the stock its 28th biggest holding. Sather Financial Group Inc’s holdings in UnitedHealth Group were worth $6,422,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the company. Udine Wealth Management Inc. acquired a new stake in UnitedHealth Group during the 2nd quarter worth $2,349,000. Sovereign Financial Group Inc. increased its holdings in UnitedHealth Group by 3.2% during the 2nd quarter. Sovereign Financial Group Inc. now owns 2,249 shares of the healthcare conglomerate’s stock worth $702,000 after purchasing an additional 69 shares in the last quarter. Asset Planning Inc grew its holdings in shares of UnitedHealth Group by 3.3% in the 2nd quarter. Asset Planning Inc now owns 1,900 shares of the healthcare conglomerate’s stock valued at $593,000 after acquiring an additional 61 shares in the last quarter. Sivik Global Healthcare LLC grew its holdings in shares of UnitedHealth Group by 200.0% in the 2nd quarter. Sivik Global Healthcare LLC now owns 15,000 shares of the healthcare conglomerate’s stock valued at $4,680,000 after acquiring an additional 10,000 shares in the last quarter. Finally, GFS Advisors LLC bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $4,524,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 3.6%

Shares of NYSE:UNH opened at $354.30 on Friday. The company has a fifty day moving average of $318.21 and a 200-day moving average of $349.25. The company has a market capitalization of $320.88 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is 38.30%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on UNH shares. Morgan Stanley raised their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Oppenheimer decreased their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Sanford C. Bernstein raised their price objective on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research report on Wednesday. KeyCorp boosted their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Barclays boosted their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.